| Mar'19 | Mar'18 | Mar'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
30,834 | 19,702 | 7,704 | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Stock-based compensation expense | ||||||
2,730 | 812 | 208 | ||||
Depreciation and amortization | ||||||
148 | 109 | 122 | ||||
Change in fair value of warrant liability | ||||||
5,452 | 972 | 150 | ||||
Stock options in exchange for consulting services | ||||||
- | 26 | - | ||||
Net amortization of premiums and discounts on short-term investments | ||||||
1,715 | 123 | - | ||||
Non-cash rent expense | ||||||
93 | - | - | ||||
Changes in operating assets and liabilities: | ||||||
Research and development incentives receivable | ||||||
255 | 767 | 1,210 | ||||
Prepaid expenses and other current assets | ||||||
801 | 305 | 325 | ||||
Accounts payable | ||||||
120 | 1,596 | 203 | ||||
Accrued expenses and other current liabilities | ||||||
-292 | 1,393 | 1,406 | ||||
Deferred rent | ||||||
-24 | -25 | 73 | ||||
Net cash used in operating activities | ||||||
-25,378 | -16,014 | -7,077 | ||||
Cash flows from investing activities: | ||||||
Purchases of property, plant and equipment | ||||||
2,600 | 136 | 238 | ||||
Purchase of short-term investments | ||||||
189,931 | 52,463 | - | ||||
Proceed from sales and maturities of short-term investments | ||||||
126,587 | 8,553 | - | ||||
Net cash provided by (used in) investing activities | ||||||
-65,944 | -44,046 | -238 | ||||
Cash flows from financing activities: | ||||||
Payment of issuance costs | ||||||
2,157 | - | - | ||||
Exercise of stock options | ||||||
206 | - | - | ||||
Proceeds from issuance of common stock in initial public offering, net of underwriting fees and discounts | ||||||
103,341 | - | - | ||||
Net cash provided by financing activities | ||||||
101,390 | 54,752 | 15,000 | ||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
-839 | 2,297 | -1,419 | ||||
Net increase in cash, cash equivalents and restricted cash | ||||||
9,229 | -3,011 | 6,266 | ||||
Supplemental disclosure of non-cash investing and financing activities: | ||||||
Conversion of convertible preferred stock warrants into common stock warrants | ||||||
86,361 | - | - | ||||
Conversion of convertible preferred stock into common stock | ||||||
7,094 | - | - | ||||
Net unrealized gain on short-term investments | ||||||
80 | -65 | - | ||||
Purchases of property and equipment included in accounts payable | ||||||
5,047 | - | - | ||||
Amounts capitalized under build-to-suit lease transaction | ||||||
4,292 | - | - | ||||
Series B convertible Preferred Stock | ||||||
Payment of issuance costs | ||||||
- | 198 | - | ||||
Proceeds from issuance of convertible preferred stock, net of issuance costs | ||||||
- | 54,752 | - | ||||
Series A convertible Preferred Stock | ||||||
Proceeds from issuance of convertible preferred stock, net of issuance costs | ||||||
- | - | 15,000 | ||||